General Tagomics introduces LiquiPath, a first-in-class cfDNA-based blood test for multi-organ drug safety monitoringBy Healthcare Propulsion StaffAugust 17, 20260 Tagomics Ltd., a pioneering precision medicine company, today announced the launch of LiquiPath™, a cross-species, multi-organ “liquid pathology” platform, for…